nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—FGF2—periodontitis	0.914	1	CbGaD
Sirolimus—EIF4E—connective tissue—periodontitis	0.00293	0.194	CbGeAlD
Sirolimus—FGF2—trigeminal ganglion—periodontitis	0.00215	0.143	CbGeAlD
Sirolimus—MTOR—neck—periodontitis	0.00158	0.105	CbGeAlD
Sirolimus—FKBP1A—neck—periodontitis	0.00142	0.0944	CbGeAlD
Sirolimus—FKBP1A—trigeminal ganglion—periodontitis	0.00123	0.0815	CbGeAlD
Sirolimus—MTOR—connective tissue—periodontitis	0.00113	0.0752	CbGeAlD
Sirolimus—MTOR—epithelium—periodontitis	0.00108	0.0714	CbGeAlD
Sirolimus—SLC47A1—trigeminal ganglion—periodontitis	0.00106	0.07	CbGeAlD
Sirolimus—FKBP1A—connective tissue—periodontitis	0.00102	0.0676	CbGeAlD
Sirolimus—FKBP1A—epithelium—periodontitis	0.000968	0.0642	CbGeAlD
Sirolimus—ABCB1—trigeminal ganglion—periodontitis	0.000284	0.0188	CbGeAlD
Sirolimus—ABCB1—epithelium—periodontitis	0.000224	0.0149	CbGeAlD
Sirolimus—MTOR—Downstream signal transduction—FGF2—periodontitis	9.66e-05	0.00136	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CD79A—periodontitis	9.64e-05	0.00135	CbGpPWpGaD
Sirolimus—MTOR—Signaling by FGFR—FGF2—periodontitis	9.61e-05	0.00135	CbGpPWpGaD
Sirolimus—MTOR—Signaling by ERBB2—FGF2—periodontitis	9.57e-05	0.00134	CbGpPWpGaD
Sirolimus—MTOR—DAP12 signaling—FGF2—periodontitis	9.52e-05	0.00134	CbGpPWpGaD
Sirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—FGF2—periodontitis	9.38e-05	0.00132	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CIITA—periodontitis	9.32e-05	0.00131	CbGpPWpGaD
Sirolimus—FGF2—Immune System—FCGR3A—periodontitis	9.28e-05	0.0013	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CD14—periodontitis	9.25e-05	0.0013	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—MMP2—periodontitis	9.23e-05	0.0013	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CXCR2—periodontitis	9.17e-05	0.00129	CbGpPWpGaD
Sirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	9.13e-05	0.00128	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—FCGR2A—periodontitis	9.01e-05	0.00127	CbGpPWpGaD
Sirolimus—MTOR—DAP12 interactions—FGF2—periodontitis	8.96e-05	0.00126	CbGpPWpGaD
Sirolimus—MTOR—Signaling by FGFR in disease—FGF2—periodontitis	8.96e-05	0.00126	CbGpPWpGaD
Sirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—FGF2—periodontitis	8.96e-05	0.00126	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—VCAM1—periodontitis	8.92e-05	0.00125	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR—FGF2—periodontitis	8.88e-05	0.00125	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—TGFB1—periodontitis	8.87e-05	0.00125	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—CD79A—periodontitis	8.84e-05	0.00124	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—CD14—periodontitis	8.82e-05	0.00124	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR in Cancer—FGF2—periodontitis	8.8e-05	0.00124	CbGpPWpGaD
Sirolimus—FGF2—Disease—ACP5—periodontitis	8.79e-05	0.00123	CbGpPWpGaD
Sirolimus—MTOR—Signaling by PDGF—FGF2—periodontitis	8.76e-05	0.00123	CbGpPWpGaD
Sirolimus—MTOR—Signaling by SCF-KIT—MMP9—periodontitis	8.5e-05	0.00119	CbGpPWpGaD
Sirolimus—FGF2—Signaling by Insulin receptor—IL6—periodontitis	8.32e-05	0.00117	CbGpPWpGaD
Sirolimus—MTOR—B Cell Activation—FGF2—periodontitis	8.29e-05	0.00116	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—VCAM1—periodontitis	8.18e-05	0.00115	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—CCL2—periodontitis	8.16e-05	0.00115	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CTSC—periodontitis	8.15e-05	0.00114	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—VDR—periodontitis	8.04e-05	0.00113	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—SLC52A3—periodontitis	7.97e-05	0.00112	CbGpPWpGaD
Sirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—FGF2—periodontitis	7.93e-05	0.00111	CbGpPWpGaD
Sirolimus—MTOR—IRS-mediated signalling—IL6—periodontitis	7.91e-05	0.00111	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CXCL3—periodontitis	7.91e-05	0.00111	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL1A—periodontitis	7.91e-05	0.00111	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL18—periodontitis	7.89e-05	0.00111	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CCR2—periodontitis	7.81e-05	0.0011	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—MMP2—periodontitis	7.76e-05	0.00109	CbGpPWpGaD
Sirolimus—MTOR—Immune System—LBP—periodontitis	7.72e-05	0.00108	CbGpPWpGaD
Sirolimus—MTOR—IRS-related events—IL6—periodontitis	7.7e-05	0.00108	CbGpPWpGaD
Sirolimus—MTOR—IRS-related events triggered by IGF1R—IL6—periodontitis	7.63e-05	0.00107	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—AGER—periodontitis	7.58e-05	0.00106	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—VIP—periodontitis	7.55e-05	0.00106	CbGpPWpGaD
Sirolimus—MTOR—Disease—LTF—periodontitis	7.52e-05	0.00106	CbGpPWpGaD
Sirolimus—MTOR—IGF1R signaling cascade—IL6—periodontitis	7.43e-05	0.00104	CbGpPWpGaD
Sirolimus—MTOR—Insulin receptor signalling cascade—IL6—periodontitis	7.43e-05	0.00104	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	7.41e-05	0.00104	CbGpPWpGaD
Sirolimus—EIF4E—Cytokine Signaling in Immune system—IL6—periodontitis	7.39e-05	0.00104	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—PPARA—periodontitis	7.37e-05	0.00103	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—SLC52A3—periodontitis	7.31e-05	0.00103	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—TLR2—periodontitis	7.26e-05	0.00102	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—AGER—periodontitis	7.24e-05	0.00102	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CCR2—periodontitis	7.13e-05	0.001	CbGpPWpGaD
Sirolimus—FGF2—Signaling by SCF-KIT—IL6—periodontitis	7.11e-05	0.000999	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—ADRB1—periodontitis	7.1e-05	0.000997	CbGpPWpGaD
Sirolimus—FGF2—Immune System—FCGR2A—periodontitis	7.07e-05	0.000993	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—MMP9—periodontitis	6.94e-05	0.000974	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—IFNG—periodontitis	6.92e-05	0.000971	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	6.92e-05	0.000971	CbGpPWpGaD
Sirolimus—MTOR—Immune System—FCGR3A—periodontitis	6.88e-05	0.000967	CbGpPWpGaD
Sirolimus—FGF2—Downstream signaling of activated FGFR—IL6—periodontitis	6.81e-05	0.000956	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—PPARA—periodontitis	6.78e-05	0.000952	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CXCR2—periodontitis	6.73e-05	0.000945	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—MET—periodontitis	6.7e-05	0.000941	CbGpPWpGaD
Sirolimus—FGF2—Signaling by ERBB4—IL6—periodontitis	6.7e-05	0.000941	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—IL6—periodontitis	6.68e-05	0.000939	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	6.64e-05	0.000933	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CRP—periodontitis	6.61e-05	0.000928	CbGpPWpGaD
Sirolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—periodontitis	6.58e-05	0.000925	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CD79A—periodontitis	6.56e-05	0.000921	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CD14—periodontitis	6.55e-05	0.00092	CbGpPWpGaD
Sirolimus—MTOR—Disease—ACP5—periodontitis	6.52e-05	0.000916	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—CXCL8—periodontitis	6.45e-05	0.000906	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—CXCL8—periodontitis	6.43e-05	0.000903	CbGpPWpGaD
Sirolimus—FGF2—Downstream signal transduction—IL6—periodontitis	6.4e-05	0.000899	CbGpPWpGaD
Sirolimus—FGF2—Signaling by FGFR—IL6—periodontitis	6.37e-05	0.000894	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—TLR4—periodontitis	6.34e-05	0.00089	CbGpPWpGaD
Sirolimus—FGF2—Signaling by ERBB2—IL6—periodontitis	6.34e-05	0.00089	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—CRP—periodontitis	6.31e-05	0.000886	CbGpPWpGaD
Sirolimus—FGF2—DAP12 signaling—IL6—periodontitis	6.3e-05	0.000885	CbGpPWpGaD
Sirolimus—MTOR—Signaling by VEGF—IL6—periodontitis	6.21e-05	0.000873	CbGpPWpGaD
Sirolimus—MTOR—Signaling by Insulin receptor—IL6—periodontitis	6.17e-05	0.000867	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—IL1B—periodontitis	6.17e-05	0.000866	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CCR2—periodontitis	6.13e-05	0.000861	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL1RN—periodontitis	6.11e-05	0.000858	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—FGF2—periodontitis	6.1e-05	0.000857	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—VCAM1—periodontitis	6.07e-05	0.000852	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—TLR4—periodontitis	6.05e-05	0.000849	CbGpPWpGaD
Sirolimus—FGF2—Signaling by FGFR in disease—IL6—periodontitis	5.93e-05	0.000833	CbGpPWpGaD
Sirolimus—FGF2—Fc epsilon receptor (FCERI) signaling—IL6—periodontitis	5.93e-05	0.000833	CbGpPWpGaD
Sirolimus—FGF2—DAP12 interactions—IL6—periodontitis	5.93e-05	0.000833	CbGpPWpGaD
Sirolimus—FGF2—Signaling by EGFR—IL6—periodontitis	5.88e-05	0.000825	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CXCL3—periodontitis	5.87e-05	0.000825	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—GGT1—periodontitis	5.87e-05	0.000824	CbGpPWpGaD
Sirolimus—FGF2—Signaling by EGFR in Cancer—IL6—periodontitis	5.83e-05	0.000818	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—NTRK1—periodontitis	5.82e-05	0.000817	CbGpPWpGaD
Sirolimus—FGF2—Signaling by PDGF—IL6—periodontitis	5.8e-05	0.000815	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—VIP—periodontitis	5.72e-05	0.000803	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—TGFB1—periodontitis	5.72e-05	0.000803	CbGpPWpGaD
Sirolimus—FGF2—Immune System—TLR2—periodontitis	5.7e-05	0.000801	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—CXCL8—periodontitis	5.69e-05	0.000799	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—MMP2—periodontitis	5.59e-05	0.000785	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—MMP3—periodontitis	5.41e-05	0.000759	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—AGER—periodontitis	5.37e-05	0.000754	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CD79A—periodontitis	5.36e-05	0.000753	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—SLC52A3—periodontitis	5.29e-05	0.000742	CbGpPWpGaD
Sirolimus—MTOR—Signaling by SCF-KIT—IL6—periodontitis	5.28e-05	0.000741	CbGpPWpGaD
Sirolimus—FGF2—NGF signalling via TRKA from the plasma membrane—IL6—periodontitis	5.25e-05	0.000738	CbGpPWpGaD
Sirolimus—MTOR—Immune System—FCGR2A—periodontitis	5.25e-05	0.000737	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CCR2—periodontitis	5.23e-05	0.000735	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—ADRB1—periodontitis	5.21e-05	0.000732	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CD14—periodontitis	5.14e-05	0.000722	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CXCR2—periodontitis	5.1e-05	0.000716	CbGpPWpGaD
Sirolimus—MTOR—Downstream signaling of activated FGFR—IL6—periodontitis	5.05e-05	0.000709	CbGpPWpGaD
Sirolimus—MTOR—Signaling by ERBB4—IL6—periodontitis	4.97e-05	0.000698	CbGpPWpGaD
Sirolimus—FGF2—Immune System—VCAM1—periodontitis	4.96e-05	0.000697	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—FGF2—periodontitis	4.91e-05	0.00069	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—TGFB1—periodontitis	4.79e-05	0.000673	CbGpPWpGaD
Sirolimus—MTOR—Downstream signal transduction—IL6—periodontitis	4.75e-05	0.000667	CbGpPWpGaD
Sirolimus—MTOR—Signaling by FGFR—IL6—periodontitis	4.72e-05	0.000663	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—GGT1—periodontitis	4.71e-05	0.000662	CbGpPWpGaD
Sirolimus—MTOR—Signaling by ERBB2—IL6—periodontitis	4.7e-05	0.00066	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ACP5—periodontitis	4.7e-05	0.00066	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CRP—periodontitis	4.68e-05	0.000657	CbGpPWpGaD
Sirolimus—MTOR—DAP12 signaling—IL6—periodontitis	4.68e-05	0.000657	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IFNG—periodontitis	4.62e-05	0.000649	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CCR2—periodontitis	4.55e-05	0.000639	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL1RN—periodontitis	4.53e-05	0.000636	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—TLR4—periodontitis	4.49e-05	0.00063	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—TNF—periodontitis	4.48e-05	0.000629	CbGpPWpGaD
Sirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—periodontitis	4.4e-05	0.000618	CbGpPWpGaD
Sirolimus—MTOR—Signaling by FGFR in disease—IL6—periodontitis	4.4e-05	0.000618	CbGpPWpGaD
Sirolimus—MTOR—DAP12 interactions—IL6—periodontitis	4.4e-05	0.000618	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL1A—periodontitis	4.4e-05	0.000617	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL18—periodontitis	4.39e-05	0.000616	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR—IL6—periodontitis	4.36e-05	0.000613	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR in Cancer—IL6—periodontitis	4.32e-05	0.000607	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ACP5—periodontitis	4.31e-05	0.000605	CbGpPWpGaD
Sirolimus—MTOR—Signaling by PDGF—IL6—periodontitis	4.3e-05	0.000604	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—NTRK1—periodontitis	4.27e-05	0.000599	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—VIP—periodontitis	4.25e-05	0.000596	CbGpPWpGaD
Sirolimus—MTOR—Immune System—TLR2—periodontitis	4.23e-05	0.000594	CbGpPWpGaD
Sirolimus—FGF2—Immune System—AGER—periodontitis	4.21e-05	0.000592	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—MMP9—periodontitis	4.2e-05	0.00059	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—periodontitis	4.2e-05	0.00059	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL1B—periodontitis	4.12e-05	0.000579	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—NOS2—periodontitis	4.08e-05	0.000573	CbGpPWpGaD
Sirolimus—FGF2—Signaling by NGF—IL6—periodontitis	4.04e-05	0.000567	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—PPARA—periodontitis	3.99e-05	0.000561	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—SLC52A3—periodontitis	3.99e-05	0.00056	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD79A—periodontitis	3.98e-05	0.000559	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CCR2—periodontitis	3.97e-05	0.000557	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—MMP3—periodontitis	3.97e-05	0.000557	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—ADRB1—periodontitis	3.95e-05	0.000554	CbGpPWpGaD
Sirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—periodontitis	3.9e-05	0.000547	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD14—periodontitis	3.81e-05	0.000536	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CXCR2—periodontitis	3.78e-05	0.000531	CbGpPWpGaD
Sirolimus—MTOR—Immune System—VCAM1—periodontitis	3.68e-05	0.000517	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CRP—periodontitis	3.67e-05	0.000516	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	3.63e-05	0.00051	CbGpPWpGaD
Sirolimus—FGF2—Immune System—TLR4—periodontitis	3.52e-05	0.000495	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CCL2—periodontitis	3.52e-05	0.000494	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—FGF2—periodontitis	3.48e-05	0.000489	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—TGFB1—periodontitis	3.46e-05	0.000486	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—FGF2—periodontitis	3.34e-05	0.000469	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—FGF2—periodontitis	3.33e-05	0.000467	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	3.27e-05	0.00046	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL1A—periodontitis	3.26e-05	0.000458	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL18—periodontitis	3.26e-05	0.000457	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—TNF—periodontitis	3.23e-05	0.000454	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NTRK1—periodontitis	3.23e-05	0.000454	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—IL6—periodontitis	3.2e-05	0.000449	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—FGF2—periodontitis	3.18e-05	0.000446	CbGpPWpGaD
Sirolimus—MTOR—Immune System—AGER—periodontitis	3.13e-05	0.000439	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ACP5—periodontitis	3.12e-05	0.000438	CbGpPWpGaD
Sirolimus—FGF2—Disease—NOS2—periodontitis	3.09e-05	0.000434	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MMP3—periodontitis	3.01e-05	0.000422	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—PTGS2—periodontitis	3e-05	0.000422	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—IL6—periodontitis	3e-05	0.000421	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCR2—periodontitis	2.94e-05	0.000413	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—ADRB1—periodontitis	2.93e-05	0.000411	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CXCL8—periodontitis	2.78e-05	0.00039	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	2.73e-05	0.000383	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CRP—periodontitis	2.73e-05	0.000383	CbGpPWpGaD
Sirolimus—MTOR—Immune System—TLR4—periodontitis	2.61e-05	0.000367	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—GGT1—periodontitis	2.61e-05	0.000367	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—IL6—periodontitis	2.61e-05	0.000366	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CCL2—periodontitis	2.58e-05	0.000362	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IFNG—periodontitis	2.57e-05	0.000361	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—MMP9—periodontitis	2.51e-05	0.000353	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—SLC52A3—periodontitis	2.46e-05	0.000345	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL6—periodontitis	2.41e-05	0.000339	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NTRK1—periodontitis	2.4e-05	0.000337	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—GGT1—periodontitis	2.4e-05	0.000337	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	2.37e-05	0.000332	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ACP5—periodontitis	2.35e-05	0.00033	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—FGF2—periodontitis	2.33e-05	0.000327	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—IL6—periodontitis	2.3e-05	0.000324	CbGpPWpGaD
Sirolimus—MTOR—Disease—NOS2—periodontitis	2.3e-05	0.000322	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL1B—periodontitis	2.29e-05	0.000322	CbGpPWpGaD
Sirolimus—FGF2—Disease—PTGS2—periodontitis	2.27e-05	0.000319	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MMP3—periodontitis	2.23e-05	0.000313	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	2.21e-05	0.00031	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—TGFB1—periodontitis	2.17e-05	0.000305	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TGFB1—periodontitis	2.07e-05	0.000291	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CXCL8—periodontitis	2.04e-05	0.000286	CbGpPWpGaD
Sirolimus—MTOR—Immune System—FGF2—periodontitis	2.03e-05	0.000285	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—PPARA—periodontitis	2e-05	0.000281	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CCL2—periodontitis	1.95e-05	0.000274	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IFNG—periodontitis	1.91e-05	0.000268	CbGpPWpGaD
Sirolimus—MTOR—Disease—FGF2—periodontitis	1.87e-05	0.000263	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PPARA—periodontitis	1.87e-05	0.000263	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—MMP9—periodontitis	1.84e-05	0.000259	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GGT1—periodontitis	1.73e-05	0.000243	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PPARA—periodontitis	1.72e-05	0.000241	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—IL6—periodontitis	1.71e-05	0.00024	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL1B—periodontitis	1.7e-05	0.000239	CbGpPWpGaD
Sirolimus—MTOR—Disease—PTGS2—periodontitis	1.69e-05	0.000237	CbGpPWpGaD
Sirolimus—FGF2—Disease—TGFB1—periodontitis	1.64e-05	0.000231	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—IL6—periodontitis	1.64e-05	0.00023	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—IL6—periodontitis	1.56e-05	0.000219	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CXCL8—periodontitis	1.54e-05	0.000217	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TGFB1—periodontitis	1.52e-05	0.000213	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCL2—periodontitis	1.45e-05	0.000204	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ACP5—periodontitis	1.45e-05	0.000203	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MMP9—periodontitis	1.4e-05	0.000196	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL6—periodontitis	1.34e-05	0.000188	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—FGF2—periodontitis	1.31e-05	0.000184	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GGT1—periodontitis	1.31e-05	0.000184	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PPARA—periodontitis	1.24e-05	0.000174	CbGpPWpGaD
Sirolimus—FGF2—Disease—IL6—periodontitis	1.24e-05	0.000174	CbGpPWpGaD
Sirolimus—MTOR—Disease—TGFB1—periodontitis	1.22e-05	0.000171	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PTGS2—periodontitis	1.22e-05	0.000171	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TGFB1—periodontitis	1.15e-05	0.000162	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CXCL8—periodontitis	1.15e-05	0.000161	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL6—periodontitis	1.15e-05	0.000161	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PTGS2—periodontitis	1.12e-05	0.000157	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MMP9—periodontitis	1.04e-05	0.000146	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL6—periodontitis	9.96e-06	0.00014	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PPARA—periodontitis	9.36e-06	0.000131	CbGpPWpGaD
Sirolimus—MTOR—Disease—IL6—periodontitis	9.2e-06	0.000129	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL6—periodontitis	8.68e-06	0.000122	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TGFB1—periodontitis	8.55e-06	0.00012	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PTGS2—periodontitis	8.07e-06	0.000113	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GGT1—periodontitis	8.06e-06	0.000113	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL6—periodontitis	6.44e-06	9.04e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PTGS2—periodontitis	6.09e-06	8.55e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PPARA—periodontitis	5.77e-06	8.1e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PTGS2—periodontitis	3.75e-06	5.27e-05	CbGpPWpGaD
